Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| IsoRay Inc | ISR | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.384 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.384 | 0.384 |
| Trades | Shares Traded | Average Volume |
|---|---|---|
| 0 | 0 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.384 | USD |
IsoRay Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 448.91M | 280.57M | - | 1.43M | -46.51M | -0.17 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
IsoRay News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/24/2024 | 15:35 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 4/19/2024 | 15:05 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 4/18/2024 | 15:11 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 4/18/2024 | 15:09 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 4/16/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/09/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 4/09/2024 | 15:25 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 4/08/2024 | 15:12 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 4/08/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/03/2024 | 15:36 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/01/2024 | 06:46 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 3/29/2024 | 06:35 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ISR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.91 | 0.9821 | 0.1922 | 0.5581734 | 536,248 | -0.526 | -57.80% |
| 5 Years | 0.41 | 2.81 | 0.1922 | 1.24 | 1,488,384 | -0.026 | -6.34% |
IsoRay Description
| Isoray Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products that provide a more cost-effective cancer treatment. It is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. Isoray derives most of its revenue from the United States of America. |
